Author:
Matsukuma Karen,Olson Kristin A,Gui Dorina,Gandour-Edwards Regina,Li Yueju,Beckett Laurel
Publisher
Springer Science and Business Media LLC
Subject
Pathology and Forensic Medicine
Reference26 articles.
1. Rindi G, Arnold R, Bosman FT et al. Nomenclature and classification of neuroendocrine neoplasms of the digestive system. In: Bosman FT, Carneiro C, Hruban RH, et al (eds). WHO Classification of Tumours of the Digestive System. World Health Organization Classification of Tumours, 4th edn. International Agency for Research on Cancer: Lyon, France, 2010, pp 13–14.
2. McCall CM, Shi C, Cornish TC et al, Grading of well-differentiated pancreatic neuroendocrine tumors is improved by the inclusion of both Ki67 proliferative index and mitotic rate. Am J Surg Pathol 2013; 37: 671–1677.
3. Khan MS, Luong TV, Watkins J et al. A comparison of Ki-67 and mitotic count as prognostic markers for metastatic pancreatic and midgut neuroendocrine neoplasms. Br J Cancer 2013; 108:838–1845.
4. van Velthuysen ML, Groen EJ, Sanders J et al.Reliability of proliferation assessment by Ki-67 expression in neuroendocrine neoplasms: eyeballing or image analysis? Neuroendocrinology 2014; 100:88–292.
5. Adsay V . Ki67 labeling index in neuroendocrine tumors of the gastrointestinal and pancreatobiliary tract: to count or not to count is not the question, but rather how to count. Am J Surg Pathol 2012; 36: 1743–1746.
Cited by
18 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献